BioVie (BIVI) Fundamental Analysis: Revenue, Earnings & Valuation

6.87 / 10

Outperform

Fundamentals score 6.87 (Outperform). Strengths include high accounts‑receivable turnover, interest coverage, PB‑ROE, revenue‑to‑market value and inventory turnover. Weak spots are fixed‑asset turnover and income‑tax ratio. Weighted factors highlight PB‑ROE, Revenue‑MV and Asset‑MV as primary drivers.

Analysis Checks(8/10)

Revenue-MV

Value-0.08

Score3/3

Weight30.47%

1M Return8.83%

Total operating revenue (YoY growth rate %)

Value134.75

Score2/3

Weight1.62%

1M Return0.58%

Inventory turnover ratio

Value106.57

Score3/3

Weight-1.73%

1M Return-0.67%

Accounts receivable turnover ratio

Value23.61

Score2/3

Weight-1.71%

1M Return-0.65%

PB-ROE

Value-0.11

Score3/3

Weight44.08%

1M Return12.56%

Income tax / Total profit (%)

Value22.35

Score0/3

Weight-3.89%

1M Return-1.54%

Fixed assets turnover ratio

Value9771.06

Score1/3

Weight-3.21%

1M Return-1.28%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight-1.93%

1M Return-0.73%

Cost of sales ratio (%)

Value57.03

Score2/3

Weight-1.90%

1M Return-0.74%

Asset-MV

Value-0.55

Score2/3

Weight38.22%

1M Return9.91%

Is BIVI undervalued or overvalued?

BIVI scores 6.87/10 on fundamentals and holds a Discounted valuation at present. Backed by its -58.52% ROE, 0.00% net margin, -0.59 P/E ratio, 0.53 P/B ratio, and 89.94% earnings growth, these metrics solidify its Outperform investment rating.